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ABSTRACT
Misfolding and associated loss of function are
common problems in constructing fusion RNA
complexes due to changes in energy landscape
and the nearest-neighbor principle. Here we report
the incorporation and application of the pRNA-3WJ
motif of the phi29 DNA packaging motor into fusion
RNA with controllable and predictable folding.
The motif included three discontinuous 18 nucleo-
tide (nt) fragments, displayed a distinct low folding
energy (Shu D et al., Nature Nanotechnology, 2011,
6:658–667), and folded spontaneously into a leading
core that enabled the correct folding of other
functionalities fused to the RNA complex. Three
individual fragments dispersed at any location
within the sequence allowed the other RNA func-
tional modules to fold into their original structures
with authentic functions, as tested by Hepatitis B
virus ribozyme, siRNA, and aptamers for malachite
green (MG), spinach, and streptavidin (STV). Only
nine complementary nucleotides were present for
any two of the three 18-nt fragments, but the
three 9 bp branches were so powerful that they dis-
rupted other double strands with more than 15bp
within the fusion RNA. This system enabled the pro-
duction of fusion complexes harboring multiple RNA
functionalities with correct folding for potential ap-
plications in biotechnology, nanomedicine and
nanotechnology. We also applied this system to in-
vestigate the principles governing the folding of
RNA in vivo and in vitro. Temporal production of
RNA sequences during in vivo transcription caused
RNA to fold into different conformations that could
not be predicted with routine principles derived
from in vitro studies.
INTRODUCTION
RNA nanotechnology involves programmable and
addressable designs of RNA 3D nanoparticles by fusing
or grafting individual RNA structural moieties or
functionalities to one another (1,2). Many RNA folding
programs are available (3–5) for RNA secondary structure
prediction. However, manipulating tertiary folding of
the reconstructed RNA is very challenging due to changes
in the nearest-neighbor and the redistribution of energy
landscapes. Development of systems to fold RNA
functionalities in a controllable and predictable manner
is therefore very desirable. It has been reported that RNA
junction motifs, such as the three-way junction (3WJ) (6–9),
four-way junction (4WJ) (10), and five-way junction (5WJ)
(11) can form stable conformations composed of discon-
tinuous RNA fragments. For example, the stable properties
of the 3WJ structural motif derived from pRNA of bac-
teriophage phi29 DNA packaging motor has been utilized
to generate functional RNA nanoparticles (6–8,12). Other
examples of in silico generated RNA nanostructures based
on RNA structural motifs include RNAI/II inverse kissing
loops (13), kink-turn structural motifs (14,15), receptor-
loop/loop-receptor interacting motifs (16,17), and phi29
pRNA hand-in-hand and foot-to-foot interactions (1,12,
18–22). In addition, tightly folded RNA motifs have been
reported in vivo that served as vectors to carry exogenous
functional RNA modules (23).
More and more non-coding RNA molecules have been
discovered to play essential roles in the regulation of a
variety of diverse biological functions in cells (24–27).
Often, the function of an RNA molecule is dependent on
its tertiary structure, as well as information encoded in its
canonical or non-canonical base pairing (28–30). Thus,
prior to in vitro or in vivo design of artificial RNA
nanoparticles, one needs to consider if the desired fusion
RNA will fold into the predicted functional structure and
retain its correct functionality. An example is the RNA
paranemic motif coupled with malachite green (MG)
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binding RNA aptamer (31) to confer rigidity and enhance
fluorescence emission (6,7,8,32).
The structural properties encoded in intracellular func-
tional RNAs are extremely important in RNA nanotech-
nology. Several methods have been applied to determine
structural properties of small and large RNAs (33–37),
including physical and chemical approaches to probe
RNA/ribonucleoprotein structures in vitro (38).
Additionally, several chemical reagents that are sensitive
to secondary and/or tertiary structures have been used for
elucidating RNA structure in vivo (34). Dimethyl sulfate
(DMS) has been extensively applied for probing RNA
structure in a variety of organisms ranging from bacteria
to eukaryotes (39,40). Lead-(II)-acetate has also been used
to probe RNA structures in bacteria (41); this ion easily
enters bacterial cells and primarily induces specific cleav-
ages at positions of tight metal ion binding. Another
chemical reagent is the hydroxyl radical (OH), which has
been widely used in nucleic acid footprinting (42). This
technique can be applied to probe RNA tertiary structure
and its intermolecular interactions.
Recently, we discovered that the pRNA-3WJ motif
(Figure 1a) exhibits unusually robust properties (6,8,43)
and can serve as a core to drive the folding of other
RNA molecules fused to the complex. The pRNA-3WJ
domain can be assembled from three pieces of RNA oligo-
nucleotides resulting in a structure with: (i) an unusually
high thermodynamic stability; (ii) highly efficient complex
assembly even in the absence of metal salts; (iii) resistance
to denaturation even in the presence of 8M urea; (iv) the
ability to stay intact without dissociating at ultra-low con-
centrations; and (v) coordination of two divalent metal
ions (6,43). Herein, we demonstrate that this robust
pRNA-3WJ motif can provide a leading core and drive
the correct folding of other functionalities fused into the
RNA complex with controllable and predictable conse-
quences. This system will enable the production of
fusion RNA with incorporated functionalities folded
into their authentic structure and function for
applications in biotechnology and nanotechnology.
MATERIALS AND METHODS
In vitro synthesis and purification of RNAs
All pRNA-3WJ constructs were prepared by in vitro tran-
scription using T7 RNA polymerase from DNA templates
amplified by polymerase chain reaction (PCR), as described
previously (44). The DNA templates and primers were
synthesized chemically by IDT (Iowa). RNAs were used
directly for MG fluorescence assays, or purified by 8M
urea 8% polyacrylamide gel electrophoresis (PAGE).
Folate binding assay
Human nasopharyngeal carcinoma KB cells [American
Type Culture Collection (ATCC)] were grown on
glass coverslides in folate-free medium overnight. Cy3-
labeled pRNA-3WJ-FA-siRNA(survivin)-Ribozyme was
incubated with the cells at 37C for 2 h. After washing
with phosphate buffered saline (PBS), the cells were
fixed by 4% paraformaldehyde and stained by Alexa
Fluor 488 phalloidin (Invitrogen) for cytoskeleton and
TO-PRO-3 iodide (642/661) (Invitrogen) for nucleus.
The cells were then assayed for binding and cell entry by
Zeiss LSM 510 laser scanning confocal microscope.
Assay for the silencing of genes in cancer cell model
KB cells were transfected with 25 nM of individual
fusion pRNA-3WJ complex using Lipofectamine 2000
Transfection Reagent (Invitrogen). After 48 h, cells were
collected and target gene silencing effects were assessed by
western blot assay, as previously described (6). Briefly,
cells were lysed by Radio-Immunoprecipitation Assay
(RIPA) lysis buffer (Sigma) and the cell total protein
was extracted for the assay. Equal amounts of proteins
were then loaded onto 15% sodium dodecyl sulfate
(SDS)–PAGE and electrophoretically transferred to
Immun-Blot PVDF membranes (Bio-rad). The
membrane was probed with survivin antibody (R&D)
(1:4000 diluted) and b-actin antibody (Sigma) (1:5000
diluted) overnight, followed by 1:10 000 anti-rabbit sec-
ondary antibody conjugated with horseradish peroxidase
(Millipore) for 1 h. Membranes were blotted by ECL kits
(Millipore) and exposed to film for autoradiography.
Binding assay for the Streptavidin-binding aptamer
Tritium-labeled [3H] RNA nanostructures (pRNA-3WJ-
MG-HBV-STV) were preassembled in binding buffer
(PBS with 10mM Mg2+) before incubation with
streptavidin (STV) agarose resin (Thermo Scientific). A
total of 50 ml aliquot of STV resin was equilibrated at
room temperature (RT) following washing with binding
buffer. In all, 5 mg RNA samples were added to each
tube and incubated with the resin for 1 h at RT. After
incubation, the resin was spun at 500 g for 1min, and
the supernatant (pass through) was removed. Then, 50 ml
binding buffer was added to the mixture and incubated for
15min to wash the resin several times. RNA was eluted by
5mM biotin solution and samples were analyzed on a
1900 TR Liquid Scintillation Counter (Packard).
Hepatitis B virus ribozyme activity assay
Hepatitis B virus (HBV) substrate was labeled with Cy3
(Mirus Bio LLC) and incubated with RNA nanoparticle
at 37C for 1 hr in Tris buffer (50mM Tris–HCl,
pH=7.5; 20mM MgCl2, 20mM NaCl). pRNA-HBV
ribozyme was used as a positive control (45). After
Figure 1. Experimental design for the construction of fusion RNA
complexes harboring multiple functionalities driven by pRNA-3WJ
core. (a) Secondary structure of the pRNA from the bacteriophage
phi29 DNA packaging motor. The central 3WJ motif is boxed.
(b) Approach for the construction of fusion RNA complexes. In the
figure, a3WJ, b3WJ, and c3WJ represent the three strands of the pRNA-
3WJ complex; 1–4 represent RNA functional modules.
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incubation, the products were run in 8M Urea, 10%
PAGE gel for fluorescence imaging.
MG aptamer fluorescence assay
Gel-purified RNAs were mixed with 2 mM Malachite
Green, tremethylmetane (MG) in binding buffer contain-
ing 100mM KCl, 5mM MgCl2 and 10mM HEPES (pH
7.4) and incubated at RT for 30min. The refolded RNA
samples were heating to 95C for 5min followed by slow
cooling to 37C prior to MG staining. Fluorescence was
measured using a fluorospectrometer (Horiba Jobin Yvon;
SPEX Fluolog-3), excited at 615 nm, scanning from 625 to
800 nm for emission (7,32,46).
Spinach fluorescence measurements
Assembled pRNA-3WJ nanoparticles (0.2 mM) fused with
Spinach aptamer in TMS buffer were mixed with DFHBI
dye (2 mM) and incubated at room temperature for 30min.
Fluorescence was measured using a fluorospectrometer
(Horiba Jobin Yvon), excited at 450 nm and scanning
from 565 to 750 nm for emission.
Vector construction for in vivo expression
A sequence of cis-ribozyme was fused onto the 30-end of
DNA templates of corresponding RNA for terminal pro-
cessing (45,46). The 50+0 (Reference), 50+6, 50+12, and
50+15were inserted between BglII/NdeI sites of expression
vector pET-3b. BglII cleavage removed the original T7
promoter in the vector to prevent any undesired sequence
in the 50-end of the RNA product. The insertion fragment
contained the T7 promoter at the 50-end. The clone was
transformed into Escherichia coli strain DH5a and recom-
binant plasmids were verified by sequencing (GENEWIZ).
RNA in vivo expression and purification
Escherichia coli strain BL21 star (DE3; Invitrogen) was
transformed by the recombinant plasmids, and the
colony was inoculated by 5ml LB medium containing
100 mg/ml ampicillin, grown at 37C, and shaken at
250 rpm until A600 nm reached 0.5. IPTG solution of
50 ml (1M) was added to 5ml of cell culture. Cells were
allowed to grow for 1.5 h, and then were pelleted and re-
suspended in 250 ml of 10mM magnesium acetate, 1mM
Tris–HCl, pH 7.4 (47). The total soluble RNAs were ex-
tracted using 500 ml of water saturated phenol (pH 4.5;
Fisher). The aqueous phase was ethanol precipitated
then dissolved in 50 ml of 0.05% DEPC treated water.
Gel electrophoresis of in vivo prepared RNAs
In vivo expressed 50+0 (reference), 50+6, 50+12, and 50+15
RNAs were analyzed by 8% PAGE gel containing 8M of
urea by loading 5ml of each sample and run in 1x TBE
(89mM Tris base, 89mM Boric acid, 2mM ethylenediami-
netetraacetic acid) at 120V, at RT for 1 h. The 8% native
PAGE gel was run in 1x TBM (89mM Tris base, 200mM
Boric acid, 5mM MgCl2, pH 8.0) at 70V, at 4
C for 3h.
After electrophoresis, the gels were stained with 10mMMG
in 100mMKCl, 5mMMgCl2, and 10mMHEPES (pH 7.4)
for 15min at RT. The MG fluorescence image was acquired
by the Cy5 channel (635nm excitation/670nm emission)
using a Typhoon scanner (48). The gels were then stained
with EB and scanned in EB channel (532nm excitation/
580nm emission).
RESULTS
pRNA-3WJ motif drives the folding of different RNA
functionalities in fusion RNA
Figure 1b shows the design principles for constructing
fusion RNA with multiple functionalities. The three
pRNA-3WJ fragments (a3WJ, b3WJ, and c3WJ) are
dispersed within the complex and serve as a driving
force for the folding of other RNA molecules. Several
RNA functionalities were incorporated and tested
in vitro including: (i) siRNA targeting survivin gene
(49,50); (ii) MG (Malachite Green dye, triphenylmethane)
binding RNA aptamer (51); (iii) Spinach RNA aptamer
(52); (iv) STV binding RNA aptamer (53); and (v) HBV
ribozyme (45). These RNA moieties are unique in their
sequences and folding properties, and exhibit different
Gibbs free energies (G). When the functional therapeutic
RNA moieties, i.e. siRNA, ribozymes or receptor-binding
aptamers, were fused to any of the three branches of the
pRNA-3WJ, the 3WJ and the incorporated RNA modules
folded independently, as validated by AFM image (Figure
2a), and retained their authentic functions, as
demonstrated by functional assays (Figure 2). The
location of the three 3WJ fragments in the fusion RNA
was not critical; but the order of appearance from 50- a3WJ,
to b3WJ, to c3WJ -3
0 (Figure 1b) was the essential factor.
Assessment of cell binding and gene silencing using fusion
pRNA-3WJ-FA-siRNA (survivin)-Ribozyme nanoparticles
A pRNA-3WJ complex was coupled with folate (FA)
ligand, survivin siRNA, and ribozyme, denoted as
pRNA-3WJ-Folate-siRNA(survivin)-Ribozyme nanopar-
ticle (Figure 2a). FA serves as a cancer cell delivery
agent via receptor mediated endocytosis (6,8,54). Cy3-
labeled pRNA-3WJ complex was incubated with FA-
receptor positive KB cells and tested for cell binding effi-
ciency. Confocal microscopy indicated strong binding of
RNA nanoparticles as demonstrated by excellent co-local-
ization of cytoplasma (green) and RNA nanoparticles
(red) (Figure 2b).
Western blot was performed to assay the gene silencing
effects of survivin siRNA in KB cells. After 48-h transfec-
tion, reduced survivin protein expression level was
observed compared to scramble controls (Figure 2c).
b-actin was used as an endogenous control. We previously
demonstrated that the mechanism of siRNA release from
pRNA nanoparticles is by Dicer processing (21).
Assessment of aptamer functionalities using fusion pRNA-
3WJ-MG-Spinach nanoparticles
MG binding RNA aptamers (51) and Spinach RNA
aptamers (52) were fused to the pRNA-3WJ scaffold
(denoted pRNA-3WJ-MG-Spinach nanoparticles) for
structure and function verification (Figure 2d). Free
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MG and DFHBI (3,5-difluoro-4-hydroxybenzylidene
imidazolinone; Spinach aptamer-binding dye) are not
fluorescent by themselves, and only emit fluorescence
after binding to the correctly folded RNA aptamers.
Both MG binding aptamer and Spinach aptamers
incorporated in the 3WJ motif retained their capacity to
bind MG and DFHBI dyes, respectively, as demonstrated
by their fluorescence emission in native PAGE (Figure 2e)
and in solution (Figure 2f).
Assessment of ribozyme catalytic activity and STV
binding using fusion pRNA-3WJ-MG-HBV-STV
nanoparticles
Tetravalent RNA nanoparticles were constructed using
pRNA-3WJ motif harboring MG binding aptamer
(6,8,32), HBV ribozyme (45), and STV aptamer (53,48)
(denoted pRNA-3WJ-MG-HBV-STV nanoparticles)
(Figure 2g). HBV ribozyme (45) was able to cleave its
135-nt RNA genome substrate into two fragments (60 nt
and 75 nt) (Figure 2h). The results are comparable to
optimized positive controls, thereby confirming that the
fused ribozyme retained its authentic structure and
function. MG aptamer also retained its capacity to bind
MG dye, as revealed by fluorescence emissions in urea
PAGE (Figure 2i) and verified by total RNA staining
with EB (Figure 2j).
For assessment of STV binding, [3H]-UTP whole chain
labeled pRNA-3WJ-MG-HBV-STV nanoparticles were
incubated with STV resin in an affinity column. The
column was washed, and the RNA nanoparticles were
then eluted with biotin (Figure 2k), indicating correct
folding of the incorporated STV aptamer. As a negative
control, RNA nanoparticles without STV aptamer did not
appear in the elution fractions.
Design principles for evaluating the power of three
pRNA-3WJ fragments to override other complementary
sequences within fusion RNA constructs
The energy landscape and nearest-neighbor principle are
key factors governing RNA folding. Due to the free-
energy minimization principle, complementary sequences
within RNA also play a critical role in the formation of
RNA 3D structures, e.g. pseudoknots, multi-way junc-
tions, and hairpins. To apply the pRNA-3WJ for
fabricating RNA nanostructures, the power of three
pRNA-3WJ fragments to override other complementary
sequences within fusion RNA complexes have to be tested.
Accordingly, fusion RNA complexes were designed based
on: (i) three fragments of pRNA-3WJ to direct the folding
of the RNA; (ii) additional 50-end interfering sequences
complementary to the internal sequence of the 3WJ; and
(iii) MG-aptamer to serve as a reporter for verification of
authentic folding (7). If the RNA is degraded or
misfolded, the MG fluorescence will disappear, and there-
fore can be used as an indicator for assessing the folding of
fusion RNA complexes.
RNA constructs containing interfering sequences have a
designated nomenclature. For instance, ‘50+12means that
12 overhanging nucleotides complementary to the MG-
aptamer sequence were added at the 50-end of the RNA
complex. Similarly, ‘50NM+12 (NM=non-matching)
means that 12 nucleotides non-complementary to the
MG-aptamer sequences were added at the 50-end of the
RNA complex. All RNA nanostructures were constructed
to contain the pRNA-3WJ and an MG aptamer (Figure
3a). Because the sequence at the 50-end appeared earlier
during transcription than the sequence at the 30-end,
single-stranded (ss) nucleotides of different lengths (6,
12, and 15 nt) were added to the 50-end, complementary
to the MG-aptamer sequence, in order to interfere with
the original folding driven by the pRNA-3WJ (Figure 3b).
Several controls were designed in which overhanging NM
nucleotides of differing lengths complementary to the
MG-aptamer sequence were added (Figure 3c). All these
Figure 2. Functional assays of fusion RNA complexes harboring
multiple functionalities. (a) Construction of RNA complex harboring
folate (FA), survivin siRNA, and ribozyme (denoted, pRNA-3WJ-FA-
siRNA (survivin)-Ribozyme) and corresponding AFM image. (b)
Confocal images showing the targeting of FA-receptor positive KB cells
by colocalization of cytoplasm (green) and RNA nanoparticles (red). Blue
represents nuclei. (c) Western blot assay showing target knockdown of
survivin protein by siRNA. b-actin serves as endogenous control. (d)
Construction of RNA complex harboring malachite green (MG) (6–
8,32,51) binding and Spinach aptamer (denoted, pRNA-3WJ-MG-
Spinach) (52). (e) The 8% native PAGE verifying the fluorogenic
properties of the two RNA aptamers. (f) Fluorescence spectra of MG
aptamer (top) and Spinach aptamer (bottom) in solution, measured by
fluorospectrometer. (g) Construction of RNA complex harboring MG
aptamer, HBV ribozyme, and streptavidin aptamer (pRNA-3WJ-MG-
HBV-STV). (h) The 8% native PAGE gel showing the catalytic activity
of the incorporated HBV ribozyme. (i) MG aptamer activity verified by
MG staining. (j) EB staining to verify the presence of RNA nanoparticles.
(k) STV binding assay using STV affinity column (53). Bound RNA
complexes were eluted by adding 5mM biotin (outlined in red).
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RNA constructs contain discontinuous motifs, such as
those observed in a pseudoknot (55–59).
We then investigated whether the folding was affected
by the discontinuous motifs prior to or after refolding
subsequent to transcription. This is particularly important
in the context of in vivo folding of RNA and for
transcribing therapeutic RNA nanoparticles directly in
the cell with unprocessed additional sequences at the 50-
or 30-ends. Measurements of fluorescence signals of RNA
complexes directly after in vitro transcription for all
pRNA-3WJ constructs suggested folding of authentic
MG-aptamer reporter system embedded within the
pRNA-3WJ (Figure 3b and c, black curves). These
results revealed that even with only nine complementary
nucleotides within the 3WJ, the folding power of the three
3WJ fragments could override more than 15 completely
complementary nucleotides that could form double-
stranded RNA within the RNA complex.
In addition, a control experiment was performed in
which the MG fluorescence intensity of the 50+12 con-
structs was compared to the construct where the 3WJ
motif was destroyed by deletion of the a3WJ strand
(Figure 4). The lower intensity of the control RNA
complex suggests that the folding of the MG aptamer
was indeed affected by the disruption of the 3WJ,
thereby confirming that all 3WJ component strands need
to be present to drive the folding of other RNA modules
into their fully functional state.
Comparison of pRNA-3WJ folding after transcription and
after refolding
To unravel the folding differences of in vitro RNA tran-
scription products before and after refolding, pRNA-
3WJ-MG emission spectra were measured. RNA tran-
scription reactions were performed, as described previ-
ously (60). The reactions were stopped by the addition
of DNase I. Fluorescence spectra of the transcribed
pRNA-3WJ-MG complex was then measured in the
presence of MG fluorophore. The pRNA-3WJ-MG
complex was then heated to 95C and slowly cooled to
37C (refolding). The fluorescence spectra of the
refolded pRNA-3WJ-MG complex was then compared
with the transcribed complex.
The fluorescence intensity was similar for all the control
RNA samples, 50+0, 50NM+6, 50NM+9, and 50NM+12,
regardless of the refolding step (Figure 3c). However,
RNA constructs 50+12 and 50+15 with 12 and 15 over-
hanging nucleotides, respectively, showed significant dif-
ferences (Figure 3b). Upon increasing the ssRNA length
at the 50-end from 6 to 12 nt, as exemplified in molecule
50+12, the fluorescence intensity after transcription was
found to be lower than after refolding. Increasing the
length of the ssRNA to 15-nt in RNA 50+15 resulted in
a larger difference (Figure 3b). These results demonstrate
that the complementary interfering sequences at the 50-end
partially disrupted the folding of pRNA-3WJ assembly
during the transcription reaction. In contrast, if the 15-
nt complementary interfering sequence is instead placed
at the 30-end, no differences in fluorescence intensity are
observed (Figure 3C, complex 30+15), which is consistent
with our interpretations.
Ratio of fluorescence signals of pRNA-3WJ prior to and
after refolding
To assess the folding differences of the pRNA-3WJ prior
to and after refolding, the integrated areas of individual
fluorescence signals of RNA constructs were measured
before and after refolding. The fluorescence ratio ‘r’ was
obtained for each RNA sample by dividing the integrated
area at 37C (after transcription) by the integrated area
after heating to 95C (after refolding). These ratios were
calculated from a minimum of four individual experiments
(Table 1). The ‘r’ value reflects the impact of discontinu-
ous motifs on the folding properties of pRNA-3WJ as a
function of the length of the interfering sequence during
transcription and after refolding (Figure 5). RNA con-
structs with non-matching sequences to the MG-aptamer
region, or with interfering sequences at the 30-end, had
Figure 3. Design principles for evaluating the power of three pRNA-3WJ fragments to override other complementary sequences within fusion RNA
constructs. (a) Schematic of the pRNA-3WJ structures showing location of the interfering nucleotides (left) and their complementary target (right).
The 2D structures of the RNA complexes with 6, 12, or 15-nt interfering sequences (b) or scramble sequence (NM stands for non-matching) (c) at the
50-end (top panel) and corresponding fluorescence spectra (bottom panel). In (b) and (c), black and red curves represent fluorescence spectra after
transcription and after refolding, respectively.
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similar ‘r’ values close to 1, indicating the effect was not
dependent on nucleotide length (Figure 5b). However, in
the presence of overhanging nucleotides that interfered
with the MG-aptamer sequence there was a correlation:
the longer the additional sequences at the 50-end, the
smaller the ‘r’ value, implying that there are fewer
pRNA-3WJ-MG constructs that folded properly during
temporal transcription (Figure 5a). The data leads to the
conclusion that the RNA folding was temporally depend-
ent. The 50-end sequences that appeared earlier during
transcription influenced the RNA folding more than the
sequences that appeared later during transcription.
In vivo assessment of the effect of temporal folding after
transcription
RNA constructs with interfering sequences of 6, 12, and
15 nt, similar to the in vitro design of the 50+0, 50+6,
50+12, and 50+15 RNA were expressed in E. coli cells.
The principle of this design was based on the following
ideas: (i) a thermodynamically stable and tightly folded
pRNA-3WJ would drive the correct folding of the MG-
aptamer; (ii) tightly folded RNA are relatively resistant to
RNase degradation in the cell (most cellular RNases
degrade ssRNA, but not dsRNA) and misfolded RNA
would be trimmed or truncated by RNase, leading to a
loss in fluorescence from the MG dye that only binds to
the appropriately folded and intact MG aptamer; and
(iii) the assay would be based on the comparison of the
sequences that affect the folding of the core of the pRNA-
3WJ-MG-aptamer. Thus, a cis-acting ribozyme sequence
was placed at the 30-end to cleave the undesired sequences
arising from uncontrolled termination of transcription at
the 30-end (Figure 6a) (45,61).
The RNA products from E. coli cells were first assayed
by 8% denaturing PAGE (Figure 6b). As reported previ-
ously, the pRNA-3WJ is resistant to 8M urea denatur-
ation (6,8), and as such, denaturing gel can be used to
detect the presence of the pRNA-3WJ-MG-aptamer
complex. Upon staining with either ethidium bromide
(EB) (Figure 6b, top) or MG dye (Figure 6b, bottom),
the 50+0 RNA, serving as a reference molecule, and the
50+6 RNA were detected on the gel as distinct bands
around 200 bp, indicating the presence of both the
pRNA-3WJ and the MG-aptamer in both constructs.
The higher yield of 50+0 RNA compared to 50+6 con-
struct indicated that the 6 complementary nucleotides at
the 50-end of 50+6 were able to disrupt the folding of the
pRNA-3WJ-MG-aptamer complex only to some extent.
However, MG-stained RNA was not detected in both
50+12 and 50+15 RNA lanes, indicating the misfolding
of those pRNA-3WJ-MG-aptamer complexes. Several
degraded products were observed between 50 and 70 bp
after EB staining (Figure 6b, top, lanes 50+12 and 50+15).
This data agreed with the in vitro data, suggesting
that RNA folding is temporally dependent during
transcription, and that the 50-end sequence appearing
earlier during transcription influenced the RNA folding
more than the sequence that appeared later during
transcription.
To verify the denaturing PAGE results, fluorescence
intensities of the RNA constructs obtained in vivo were
measured further in presence of MG dye (Figure 6c), in
a manner similar to that of the in vitro experiments
(Figure 3). The fluorescence intensities were detected for
both 50+0 and 50+6 constructs (Figure 6c, black curves).
But, the 50+0 RNA showed higher fluorescence value
than the 50+6 construct with six interfering nucleotides.
There was almost no fluorescence detected for constructs
50+12 and 50+15. These data are consistent with MG-
stained denaturing PAGE, suggesting that while six
interfering nucleotides partially disrupted the folding of
pRNA-3WJ-MG-aptamer, 12 and 15 nt complementary
Figure 5. Correlation between the length of the interfering sequence
and the ratio of fluorescence signals after transcription and after re-
folding. (a) Descending trend of the ratio of fluorescence signals before
and after refolding in accordance with the increasing length of the 50-
end interference sequences. (b) Control complexes with scrambled or
non-matching sequences do not exhibit any change.
Figure 4. MG fluorescence intensity of the 50+12 RNA construct com-
pared to the construct where the 3WJ motif was destroyed by deletion
of the a3WJ strand. (a–b) The 2D structures of the 5
0+12 RNA com-
plexes without (a) and with (b) deletion of a3WJ strand. (c) Comparison
of MG fluorescence spectra for RNA constructs in (a) and (b).
Table 1. Ratio (‘r’) values of RNA nanostructures after transcription
and after refolding
RNA ssRNA length (nt) Ratio (37C/95C)
50-end 30-end
50+15 15 – 0.49±0.07
50+12 12 – 0.83±0.08
50+6 6 – 1.26±0.20
50+0 – – 1.06±0.20
50NM+12 12 – 1.28±0.30
50NM+9 9 – 1.39±0.30
50NM+6 6 – 1.29±0.20
30NM+15 – 15 1.31±0.30
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sequences completely interfered with the formation of
pRNA-3WJ-MG-aptamer structures in vivo.
To refold the in vivo RNA products of pRNA-3WJ-
MG-aptamer, the denaturation and refolding step was
performed by heating the RNA solution to 95C and
slowly cooling to 37C. Interestingly, the measured fluor-
escence intensities were significantly reduced or were not
detected at all (Figure 6c, red curves). These data are in
sharp contrast to that obtained from the in vitro experi-
ments. The plot of ratio versus nucleotide length from the
in vitro RNA folding experiment resulted in a descending
trend (Figure 5a), which was not observed for in vivo
samples. The results suggest that RNA folding in vivo
and in vitro are not always identical. Correctly folded
50+12 or 50+15 RNA were significantly recovered after
denaturation and refolding (Figure 3b). However, the
misfolded in vivo 50+12 and 50+15 RNA constructs, if
any, could not be recovered upon refolding (Figure 6c).
Comparison of the sequences with their complementary
partners
The folding properties of discontinuous 3WJ-pRNA were
further analyzed by a prediction algorithm using free
energy minimization parameters and mfold (4). The goal
was to investigate how different lengths at the 50-end
contributed to the disruption of the 3WJ-pRNA con-
structs, and whether there was a relationship between
this influence and the predicted free energy of the added
sequences on their partners. The following free energies
for the duplexes of 50- or 30-end overhanging sequences
and their complementary partners were calculated at
10-4M RNA in the presence of 1M NaCl:
G= 6.1 kcal/mole for the 50+6 RNA
G=19.4 kcal/mol for the 50+12 RNA
G=25.6 kcal/mol for the 50+15 RNA
G=26.6 kcal/mol for the 30+15 RNA (control)
The longest construct with a 15-nt complementary
sequence had the highest stability with a G of
25.6 kcal/mol. This indicates that the folding of the
3WJ-pRNA complex 50+15 during in vitro transcription
was strongly interfered. This theoretical data was consist-
ent with the correlation observed by fluorescence measure-
ments of ‘r’ values. The 30-end interfering sequences
resulted in the lowest free energy value, G=
26.6 kcal/mol. This sequence did not interfere with the
MG fluorescence signal since the transcription reaction
occurs from the 50 to the 30-end, and the 15-nt region
was produced after the 3WJ complex had folded.
DISSCUSION
With the recent emergence of RNA nanotechnology (2),
development of new systems to investigate the folding of
RNA nanostructures has become very desirable. It has
been reported that RNA junction motifs, such as 3WJs,
4WJs, and 5WJs can form rigid structures composed of
discontinued RNA fragments (6, 8,10,11). The application
of robust RNA motifs as vectors to carry exogenous func-
tional moieties has been reported (23,6,8,12,48). The
novelty here is not the application of the RNA motif as
vector, but the use of the unique pRNA-3WJ with favor-
able thermodynamic attributes to drive the assembly of
fusion RNA complexes (6,8). The energy landscape in
RNA folding remains fundamentally important. When
many motifs with similar levels of folding energies are
fused into one large RNA molecule, new complementary
sequences will appear and redistribution of energy land-
scape following the nearest neighboring principle will
occur.
The pRNA-3WJ motif can be assembled from three
pieces of RNA oligonucleotides with a TM slope close to
90 (6,8). The resulting three-component complex was re-
sistant to 8M Urea denaturation and does not dissociate
Figure 6. In vivo study of 3WJ-MG RNA complexes with 50-end interfering sequences. (a) Design of in vivo study of RNA complexes with cis-acting
ribozyme, MG aptamer, and interfering sequences. (b) MG folding assayed by 8% denaturing PAGE gel stained by EB and MG. Total soluble RNA
fraction were extracted from E. coli after 1.5 h of IPTG induction. (c) Normalized fluorescence intensities of the in vivo expressed RNA constructed
after transcription (black) and after refolding (red) for 50+0, 50+6, 50+12, and 50+15 RNA constructs.
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at extremely low concentrations (6,8). The three compo-
nents had a much higher affinity for favorable interactions
compared to any of the two components, indicating co-
operative simultaneous folding of the three helical stems.
The incorporation of a pRNA-3WJ with distinct low
folding energy will provide a leading motif to drive the
folding of other functional motifs with weaker folding
forces. Thus, functional modules with weaker folding
forces will be able to fold independently into their
original authentic structure when linked to the branches
of the pRNA-3WJ.
CONCLUSIONS
The thermodynamically ultrastable pRNA-3WJ motif of
phi29 motor pRNA can be used to drive the folding of
fused RNA molecules with controllable and predictable
consequences. When a large fusion RNA molecule is con-
structed containing three individual 18-nt fragments
dispersed at any location within the sequence, the three
fragments drive the correct folding of other RNA
functionalities or motifs into their original 3D structures
with authentic functions. This approach offers a new
system for future investigations into the important topic
of RNA folding in vivo.
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